Physician

Paul C Utrie, MD

According to 2025 Medicare claims, Paul Utrie, MD (NPI: 1326065368) practices rheumatology in the Green Bay, WI market, with the plurality of this provider's patient population coming from Brown, WI. This provider's primary affiliated billing organization is ORTHOPEDIC & SPORTS MEDICINE SPECIALISTS OF GREEN BAY, SC (NPI: 1760670145; TIN: 261132759) and primary practice location at 54311-6213. Utrie is affiliated with the HSHS ACO, L.L.C. (ACO ID: A2783), OSF Healthcare System (ACO ID: A3289), AdvantagePoint Health Alliance - Great Lakes, LLC (ACO ID: A4652), THEDACARE ACO (ACO ID: A4988), and Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Utrie's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 438 traditional Medicare patients, billed 129,244 HCPCS/CPT codes, and received $1,788,497 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 5,503 prescription claims across 760 beneficiaries totaling $3,043,868 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 59 records totaling $1,000. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $978,660 to $3,043,868. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	450	123,951	$1,259,178
2016	517	172,126	$1,868,269
2017	494	188,381	$2,052,167
2018	520	112,885	$1,724,570
2019	491	137,405	$1,733,077
2020	482	135,654	$1,982,900
2021	494	127,866	$1,761,301
2022	482	119,546	$1,682,707
2023	437	119,301	$1,531,693
2024	438	129,244	$1,788,497

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	655	6,008	$978,660
2016	760	7,249	$1,211,137
2017	737	7,121	$1,452,219
2018	728	7,165	$1,772,960
2019	727	6,703	$1,991,259
2020	717	6,309	$1,957,917
2021	736	5,522	$2,047,898
2022	762	5,422	$2,315,497
2023	736	5,445	$3,202,224
2024	760	5,503	$3,043,868

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	104	260	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	302	528	$85
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	107	301	$47
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	184	239	$11
J7050	Infusion, normal saline solution, 250 cc	184	561	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	76	2,744	$727,414
Humira(Cf)	Adalimumab	30	954	$432,209
Rinvoq	Upadacitinib	47	1,410	$311,241
Enbrel Sureclick	Etanercept	23	812	$212,545
Humira	Adalimumab	17	700	$165,607

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	59	$1,000	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Paul C. Utrie, MD?

Tedicare shows public-source Medicare data for Paul C. Utrie, MD (NPI 1326065368), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Paul C. Utrie, MD have ACO affiliation data?

Paul C. Utrie, MD is shown with ACO affiliation data for HSHS ACO, L.L.C. (MSSP, ACO ID A2783), OSF Healthcare System (MSSP, ACO ID A3289), AdvantagePoint Health Alliance - Great Lakes, LLC (MSSP, ACO ID A4652), THEDACARE ACO (MSSP, ACO ID A4988), and Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Paul C. Utrie, MD?

Paul C. Utrie, MD is linked to ORTHOPEDIC & SPORTS MEDICINE SPECIALISTS OF GREEN BAY, SC (billing NPI 1760670145) in the available physician profile data.

Does Paul C. Utrie, MD have Open Payments data?

Paul C. Utrie, MD has 59 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.